reach usupdatesblogsfieldscommon questions
archiveindexconversationsmission

‘I Hate Losing’: Walter Rushes Makeover as DOJ Probes His Empire

August 17, 2026 - 04:59

‘I Hate Losing’: Walter Rushes Makeover as DOJ Probes His Empire

The man who controls Guggenheim Partners and owns the Los Angeles Dodgers is moving fast to change his financial picture. Under pressure from a federal probe, he has already sold the Los Angeles Lakers stake he bought less than a year ago, and he is looking at other ways to cut down on debt tied to his insurance companies.

People familiar with the matter say the executive, known for his intense competitive streak, is pushing through a series of deals at a pace that surprises even longtime associates. "I hate losing," he has told confidants, and that sentiment now applies to his balance sheet as much as to his sports teams.

The Justice Department is examining whether his insurance units were used improperly to fund his personal and business ventures. That inquiry has forced him to rethink how he manages his sprawling holdings, which include real estate, media, and financial services.

In recent weeks, he has explored selling stakes in other assets, including some of his more illiquid investments. The goal is to raise cash and pay down billions in loans that came from his own insurers. That arrangement, while legal in many cases, has drawn extra attention from regulators who want to see if policyholder money was put at risk.

His team has declined to comment on the specifics of the probe, but they insist the moves are not an admission of wrongdoing. Instead, they frame the sales as part of a broader strategy to simplify the empire and reduce leverage.

The Lakers flip, completed in a matter of months, was the most visible sign of this shift. He bought a minority stake in the team in early 2024, then sold it before the end of the year at a reported profit. That quick turnaround raised eyebrows, but it also gave him a fast infusion of cash.

Now, the question is what else he might let go. Sources say he has received interest from buyers for several of his smaller media properties, and he is weighing offers on some commercial real estate holdings.

The clock is ticking. The DOJ probe is still in its early stages, but the pressure is already reshaping how he does business. For a man who built his reputation on winning at all costs, the next few months will test whether he can turn a legal headache into a strategic advantage.


MORE NEWS

Should You Buy Meta Platforms Stock Below $600 Before Mark Zuckerberg Unveils Its AI Cloud Business? Here's My Honest Take

August 16, 2026 - 23:17

Should You Buy Meta Platforms Stock Below $600 Before Mark Zuckerberg Unveils Its AI Cloud Business? Here's My Honest Take

Meta Platforms is sitting just below the six hundred dollar mark, and there is a lot of chatter about what comes next. The big draw is the upcoming announcement from Mark Zuckerberg about the...

Iran business leader admits U.S. blockade will inflict more economic damage than war, and the ‘worst thing that could happen’ is trying to evade it

August 16, 2026 - 03:58

Iran business leader admits U.S. blockade will inflict more economic damage than war, and the ‘worst thing that could happen’ is trying to evade it

The head of the Iran-China Joint Chamber of Commerce has made a rare public admission that the ongoing U.S. economic blockade will cause more damage to Iran`s economy than a direct military...

Despite Mamdani’s Attempts to Appease, Many Business Leaders Remain Wary

August 15, 2026 - 03:30

Despite Mamdani’s Attempts to Appease, Many Business Leaders Remain Wary

The mayor`s latest effort to build a bridge to the business community is off to a rocky start. An attempt to form a new advisory council has run into resistance, as several prominent executives...

FDA approves new Alzheimer’s PET imaging agent from Lantheus

August 14, 2026 - 22:25

FDA approves new Alzheimer’s PET imaging agent from Lantheus

The U.S. Food and Drug Administration has approved a new imaging agent designed to help diagnose Alzheimer`s disease in adults. The drug, sold under the brand name Tauklarify and developed by...

read all news
suggestionsreach usupdatesblogsfields

Copyright © 2026 Groevo.com

Founded by: Lily Pacheco

common questionsarchiveindexconversationsmission
privacy policycookie policyuser agreement